TOMS Capital Investment Management has amassed a stake in Kenvue Inc. and is pushing for changes at the consumer health ...

Johnson & Johnson’s consumer health spinout Kenvue is quickly amassing a track record of being a target for activist ...

Kenvue Inc. (KVUE) shares will likely draw investor attention Monday morning following a Bloomberg report over the weekend ...

Most headaches don’t endanger your life, but occasionally a headache is a symptom of a very serious condition. Learn the ...

Buying Canadian can be more complicated than it sounds, especially when it comes to medications and medical supplies.

Warrants for Homan also allege she took a quantity of Oxycodone/Acetaminophen (APAP) from a patient. The South Carolina Attorney General’s Office will prosecute the case. Homan is facing up to ...

Bayer's move leaves Merck still out in front – with an approval for gefapixant for cough in Japan where the drug is known as Lyfnua – but clearly casts a shadow on the class as a whole.

According to Research by SNS Insider, Pain Management Market Growth is Fueled by Rising Chronic Pain Cases and Technological Innovations.Pune, March 18, 2025 (GLOBE NEWSWIRE) -- According to SNS ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

European Union leaders said on Thursday that they will continue to support Ukraine, but they did not immediately endorse a call by Ukrainian President Volodymyr Zelenskiy to provide at least 5 ...

Instead, consider taking simple analgesics like ibuprofen (Advil, Motrin), naproxen (Aleve), or acetaminophen (Tylenol) alone to treat migraine. That said, it’s also important not to take simple ...

Bayer has filed for approval in the US for elinzanetant as a non-hormonal treatment for menopausal symptoms such as hot flushes, with a rival therapy from Astellas in its sights. The FDA ...